Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily
(QD), taken with simvastatin on cholesterol levels in subjects with primary dyslipidemia